Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Detection of Contrast Induced Nephropathy After Coronary Angiography : Predictive Value of Osteopontin

NCT05547581 is registered in ClinicalTrials.gov with Noura gamal as lead sponsor.

NCT NCT05547581
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05547581 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Detection of Contrast Induced Nephropathy After Coronary Angiography : Predictive Value of Osteopontin
Lead sponsor
Noura gamal
Phase
Observational
Overall status
Unknown status
Start date
December 7, 2022
Completion date
December 8, 2024
Enrollment
155 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

contrast-induced nephropathy